We’re extremely pleased to announce that the Sonablate High Intensity Focused Ultrasound (HIFU) has been approved by the FDA.
HIFU has been used to treat prostate cancer around the world for years now. It can have the same effect as surgery or radiation, but with fewer side effects. In addition, the procedure is much less invasive than other treatment options. This approval is an important milestone in treating prostate cancer across the country.